Markets:

Overview

News

Currencies

International

Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

7.420 -0.180 (-2.37%)

Streaming Delayed Price Updated: 9:37 AM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 4 5 6 Next >

Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer

February 21, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Posts First Human Data For Cardiovascular Candidate ↗

February 09, 2022

Silence Therapeutics plc (NASDAQ: SLN) showed that its RNAi technology could

Via Benzinga

Silence Therapeutics Announces Positive Topline Data in SLN360 Phase 1 Single-Ascending Dose Study in Healthy Adults with High Lipoprotein(a)

February 09, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces SLN360 Phase 1 Data Accepted for Late-Breaking Presentation at the American College of Cardiology (ACC) Annual Scientific Session and Expo

January 26, 2022

From Silence Therapeutics plc

Via Business Wire

51 Biggest Movers From Yesterday ↗

January 26, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...

Via Benzinga

Silence Therapeutics’ Head of Molecular Design Dr. Marie Wikström Lindholm Appointed to Oligonucleotide Therapeutics Society Board of Directors

January 18, 2022

From Silence Therapeutics plc

Via Business Wire

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO ↗

October 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...

Via Benzinga

Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript ↗

August 12, 2021

SLN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Silence Therapeutics' siRNA Candidate Reduces Plasma Iron Levels, Early-Stage Study Shows ↗

May 19, 2021

Silence Therapeutics plc (NASDAQ: SLN) has announced topline data from GEMINI Phase 1 study evaluating SLN124 for iron-loading anemia conditions, thalassemia, and...

Via Benzinga

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics ↗

May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

Via Benzinga

Silence Therapeutics Plc (SLN) Q4 2020 Earnings Call Transcript ↗

May 03, 2021

SLN earnings call for the period ending December 31, 2020.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 29, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX) stock rose 21.78% to $8.05 during Thursday's regular session. As of 12:32 EST, Galera Therapeutics's stock is trading at...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.